FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for sirolimus from Mylan Pharmaceuticals Inc., authorizing changes to the existing product approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

SUPPL AP for SIROLIMUS (SIROLIMUS)